Eden Research (LON:EDEN) Shares Down 3.3% – Should You Sell?

Eden Research plc (LON:EDEN)’s share price traded down 3.3% on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a fifty day simple moving average of GBX 3.88 and a 200 day simple moving average of GBX 3.95. The stock has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Transactions at Eden Research

In other Eden Research news, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction on Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.